NCT02256735View on ClinicalTrials.gov

Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2005

Conditions
Healthy
Interventions
DRUG

Treatment A

Ritobegron Cl (KUC 7483 CL) tablets low dose

DRUG

Treatment B

DRUG

Treatment C

DRUG

Treatment D

DRUG

Placebo

DRUG

Moxifloxacin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02256735 - Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter